Qiagen N.V. (QGEN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Qiagen N.V. (QGEN) is down 19.5% since the beginning of the year. At $36 per share, QGEN is trading 37.2% below its 52-week high of $58. Investors who bought $1,000 worth of QGEN shares 5 years ago would now be looking at an investment worth $769.

Qiagen N.V. (QGEN) has returned -19.46% so far this year and -22.14% over the past 12 months. Over the last ten years, QGEN has returned 5.65% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Jun 28, 1996, QGEN's average daily return is +0.07%, while the average monthly return is +1.44%. At this rate, an investment would double in approximately 4.0 years.

Historically, 50% of months were positive and 50% were negative. The best month was Feb 2000 with a return of +76.5%, while the worst month was Jul 2002 at -40.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, QGEN closed higher 50% of trading days. The best single day was Jan 10, 2000 with a return of +25.0%, while the worst single day was Jul 3, 2002 at -30.0%.

Qiagen N.V. has an annualized alpha of 10.58%, beta of 0.80, and R2 of 0.14 versus S&P 500 Index. Calculated based on daily prices since June 28, 1996.

• This stock captured 104.16% of S&P 500 Index gains but only 95.98% of its losses - a favorable profile for investors.
• R2 of 0.14 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

QGEN ranks 15 for risk / return — in the bottom 15% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

Qiagen N.V. provided a 7.04% dividend yield over the last twelve months, with an annual payout of $2.55 per share.

The table displays the monthly dividend distributions for Qiagen N.V.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Qiagen N.V.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Qiagen N.V. was 92.14%, occurring on Oct 2, 2002. The portfolio has not yet recovered.

The current Qiagen N.V. drawdown is 36.55%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Qiagen N.V. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Qiagen N.V. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.